Allworth Financial LP raised its holdings in Cigna Co. (NYSE:CI – Get Rating) by 15.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,995 shares of the health services provider's stock after acquiring an additional 390 shares during the quarter. Allworth Financial LP's holdings in Cigna were worth $789,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of CI. Country Trust Bank lifted its holdings in Cigna by 116.7% in the 1st quarter. Country Trust Bank now owns 104 shares of the health services provider's stock valued at $25,000 after acquiring an additional 56 shares during the last quarter. Wagner Wealth Management LLC raised its holdings in Cigna by 144.4% during the 4th quarter. Wagner Wealth Management LLC now owns 132 shares of the health services provider's stock worth $30,000 after buying an additional 78 shares during the period. Exane Derivatives raised its holdings in Cigna by 6,200.0% during the 1st quarter. Exane Derivatives now owns 126 shares of the health services provider's stock worth $30,000 after buying an additional 124 shares during the period. Lloyd Advisory Services LLC. acquired a new stake in Cigna during the 1st quarter worth about $30,000. Finally, Vectors Research Management LLC acquired a new stake in Cigna during the 4th quarter worth about $31,000. 89.54% of the stock is owned by institutional investors and hedge funds.
Get Cigna alerts:Cigna Stock Down 1.8 %
Shares of Cigna stock opened at $277.77 on Friday. The stock has a market capitalization of $84.75 billion, a P/E ratio of 16.56, a PEG ratio of 1.11 and a beta of 0.71. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.67. The stock has a 50 day moving average price of $283.44 and a two-hundred day moving average price of $265.38. Cigna Co. has a 12-month low of $191.74 and a 12-month high of $296.29.
Cigna (NYSE:CI – Get Rating) last announced its earnings results on Thursday, August 4th. The health services provider reported $6.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.62 by $0.60. The firm had revenue of $45.48 billion during the quarter, compared to analysts' expectations of $44.34 billion. Cigna had a return on equity of 15.91% and a net margin of 3.05%. The company's revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.24 earnings per share. Equities analysts expect that Cigna Co. will post 22.94 earnings per share for the current year.Cigna Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 22nd. Stockholders of record on Wednesday, September 7th were given a $1.12 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $4.48 annualized dividend and a dividend yield of 1.61%. Cigna's dividend payout ratio is 26.71%.
Analyst Upgrades and Downgrades
CI has been the topic of several recent analyst reports. Mizuho boosted their price objective on Cigna from $291.00 to $330.00 and gave the stock a "buy" rating in a report on Friday, August 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on Cigna from $236.00 to $284.00 in a report on Thursday, June 9th. SVB Leerink boosted their price objective on Cigna from $276.00 to $305.00 and gave the stock a "market perform" rating in a report on Wednesday, August 10th. Sanford C. Bernstein upped their target price on Cigna from $258.00 to $301.00 and gave the company a "mkt perform" rating in a report on Friday, May 27th. Finally, Morgan Stanley upped their target price on Cigna from $296.00 to $318.00 and gave the company an "overweight" rating in a report on Wednesday, August 17th. Seven analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Cigna presently has an average rating of "Moderate Buy" and a consensus target price of $305.58.
Insider Activity
In other news, insider Jason D. Sadler sold 9,505 shares of the stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $280.00, for a total value of $2,661,400.00. Following the completion of the sale, the insider now directly owns 32,853 shares of the company's stock, valued at $9,198,840. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Jason D. Sadler sold 9,505 shares of the stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $280.00, for a total value of $2,661,400.00. Following the completion of the sale, the insider now directly owns 32,853 shares of the company's stock, valued at $9,198,840. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Paul A. Sanford sold 374 shares of the stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $285.00, for a total value of $106,590.00. Following the completion of the sale, the executive vice president now directly owns 9,121 shares of the company's stock, valued at $2,599,485. The disclosure for this sale can be found here. Over the last three months, insiders sold 41,158 shares of company stock valued at $11,581,956. 0.80% of the stock is owned by company insiders.
Cigna Company Profile
(Get Rating)
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Get a free copy of the StockNews.com research report on Cigna (CI)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.